Keiko Miyakoda

Suggest Changes
Learn More
The outcome in patients with human epidermal growth factor receptor-2 (HER-2)-positive locally advanced breast cancer may be improved by integrating trastuzumab with primary systemic therapy (PST).(More)
  • 1